基于内毒素的预防和治疗革兰氏阴性菌败血症及感染性休克的分子策略。 - Suppr

Suppr

超能文献

Endotoxin-based molecular strategies for the prevention and treatment of gram-negative sepsis and septic shock.

作者信息

Pollack M, Ohl C A

机构信息

Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4799, USA.

出版信息

Curr Top Microbiol Immunol. 1996;216:275-97. doi: 10.1007/978-3-642-80186-0_13.

DOI:10.1007/978-3-642-80186-0_13

PMID:8791745

Abstract

摘要

相似文献

Endotoxin-based molecular strategies for the prevention and treatment of gram-negative sepsis and septic shock.基于内毒素的预防和治疗革兰氏阴性菌败血症及感染性休克的分子策略。

Curr Top Microbiol Immunol. 1996;216:275-97. doi: 10.1007/978-3-642-80186-0_13.

Antiendotoxin strategies.抗内毒素策略

Infect Dis Clin North Am. 1999 Jun;13(2):371-86, ix. doi: 10.1016/s0891-5520(05)70080-5.

Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.用针对细菌脂多糖核心糖脂和脂质A的抗体对革兰氏阴性菌败血症和休克进行免疫预防和免疫治疗。

Infection. 1991 Nov-Dec;19(6):383-90. doi: 10.1007/BF01726444.

Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.用于预防和治疗脓毒性休克的抗内毒素策略。新方法与未来方向。

Drugs. 1998 Apr;55(4):497-508. doi: 10.2165/00003495-199855040-00002.

Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.革兰氏阴性菌败血症的过继性免疫疗法：脂多糖单克隆抗体的应用。

Crit Care Med. 1993 Feb;21(2 Suppl):S32-9. doi: 10.1097/00003246-199302001-00007.

Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.用于治疗革兰氏阴性菌血症和脓毒性休克的抗脂多糖及抗肿瘤坏死因子/恶病质素抗体

Prog Clin Biol Res. 1991;367:141-59.

Therapies for sepsis. Emerging therapies for sepsis and septic shock.脓毒症的治疗方法。脓毒症和脓毒性休克的新兴治疗方法。

West J Med. 1997 Mar;166(3):195-200.

Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.革兰氏阴性菌败血症、败血症综合征及抗内毒素单克隆抗体的作用

Clin Pharm. 1992 Mar;11(3):223-35.

Diversity in lipid A binding ligands: comparison of lipid A monoclonal antibodies with rBPI23.脂多糖A结合配体的多样性：脂多糖A单克隆抗体与重组杀菌/通透性增加蛋白23的比较

Prog Clin Biol Res. 1995;392:453-63.

Passive immunotherapy of gram-negative bacteremia, sepsis and septic shock.革兰氏阴性菌血症、败血症及感染性休克的被动免疫疗法。

Acta Clin Belg. 1993;48(1):20-9. doi: 10.1080/17843286.1993.11718281.

引用本文的文献

Change in alkaline phosphatase activity associated with intensive care unit and hospital length of stay in patients with septic acute kidney injury on continuous renal replacement therapy.接受持续肾脏替代治疗的脓毒症急性肾损伤患者，其碱性磷酸酶活性变化与重症监护病房及住院时间的关系

BMC Nephrol. 2018 Sep 20;19(1):243. doi: 10.1186/s12882-018-1028-9.

Agonistic and antagonistic properties of a Rhizobium sin-1 lipid A modified by an ether-linked lipid.一种由醚键连接脂质修饰的中华根瘤菌sin-1脂多糖A的激动和拮抗特性

Org Biomol Chem. 2007 Jul 7;5(13):2087-97. doi: 10.1039/b704427e. Epub 2007 May 29.

A nonsubstituted primary hydroxyl group in position 6' of free lipid A is required for binding of lipid A monoclonal antibodies.游离脂质A的6'位上的非取代伯羟基是脂质A单克隆抗体结合所必需的。

Infect Immun. 1997 Sep;65(9):3961-5. doi: 10.1128/iai.65.9.3961-3965.1997.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验